The Best Chemistry compound:50-84-0

About 2,4-Dichlorobenzoic acid, If you have any questions, you can contact Bennai, N; Chabrier, A; Fatthalla, MI; Tran, C; Yen-Pon, E; Belkadi, M; Alami, M; Grimaud, L; Messaoudi, S or concate me.. SDS of cas: 50-84-0

SDS of cas: 50-84-0. In 2020 J ORG CHEM published article about KINETIC DIASTEREOSELECTIVE ACYLATION; ALKYLATING-AGENTS; GLYCOSYL DONORS; IN-VITRO; GLUCURONIDES; DERIVATIVES; OXIDATION; GLUCOSIDES; DELIVERY; ESTERS in [Bennai, Nedjwa; Chabrier, Amelie; Fatthalla, Maha, I; Tran, Christine; Yen-Pon, Expedite; Alami, Mouad; Messaoudi, Samir] Univ Paris Saclay, CNRS, BioCIS, F-92290 Chatenay Malabry, France; [Bennai, Nedjwa; Belkadi, Mohamed] Univ Sci & Technol Oran Mohamed Boudiaf, Bir El Djir 31000, Algeria; [Fatthalla, Maha, I] Helwan Univ, Fac Sci, Dept Chem, Ain Helwan 11795, Egypt; [Grimaud, Laurence] Sorbonne Univ, Lab Biomol LBM, Ecole Normale Super, CNRS, F-75005 Paris, France in 2020, Cited 55. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0.

We have discovered a new mode of reactivity of 1-thiosugars in the presence of Cu(II) or Co(II) for a stereoselective O-glycosylation reaction. The process involves the use of a catalytic amount of Cu(acac)(2) or Co(acac)(2) and Ag2CO3 as an oxidant in alpha,alpha,alpha-trifluorotoluene. Moreover, this protocol turned out to have a broad scope, allowing the preparation of a wide range of complex substituted O-glycoside esters in good to excellent yields with an exclusive 1,2-trans-selectivity. The late-stage modification of pharmaceuticals by this method was also demonstrated. To obtain a closer insight into the reaction mechanism, cyclic voltammetry was performed.

About 2,4-Dichlorobenzoic acid, If you have any questions, you can contact Bennai, N; Chabrier, A; Fatthalla, MI; Tran, C; Yen-Pon, E; Belkadi, M; Alami, M; Grimaud, L; Messaoudi, S or concate me.. SDS of cas: 50-84-0

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics